INVS

Chr 9AR

inversin

Also known as: INV, NPH2, NPHP2

The protein contains multiple ankyrin domains and functions as a molecular switch in Wnt signaling pathways, targeting disheveled for degradation and organizing apical junctions in kidney cells to support normal renal development and left-right axis determination. Mutations cause nephronophthisis type 2, an infantile-onset autosomal recessive ciliopathy affecting the kidneys. The gene is not highly constrained against loss-of-function variants.

GeneReviewsOMIMResearchSummary from RefSeq, OMIM, UniProt
MultiplemechanismARLOEUF 0.921 OMIM phenotype
Clinical SummaryINVS
🧬
Gene-Disease Validity (ClinGen)
nephronophthisis 2 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📖
GeneReview available — INVS
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.92LOEUF
pLI 0.000
Z-score 2.02
OE 0.69 (0.530.92)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
1.07Z-score
OE missense 0.87 (0.810.94)
502 obs / 574.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.69 (0.530.92)
00.351.4
Missense OE0.87 (0.810.94)
00.61.4
Synonymous OE0.94
01.21.6
LoF obs/exp: 35 / 50.5Missense obs/exp: 502 / 574.1Syn Z: 0.65
DN
0.6260th %ile
GOF
0.6834th %ile
LOF
0.3941th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

INVS · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →